Mutations in SMAD1 have been related to PAH, and functional studies have confirmed the decrease in signaling due to missense variants34, but the exact molecular mechanism that leads to PAH remains unknown35. This evidence concerns the gene SMAD1 and pulmonary arterial hypertension.